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Abstract: Aim: Reviewing the effects of soy isoflavones and red clover isoflavones on the incidence of hot flushes in 
menopausal women.  Method: search articles via database: Proquest, Scopus, and ScienceDirect, Limits of 
2007-2017 there are 13 RCT research journals. Results: Of the 13 journals of 10 journals using soy 
isoflavones intervention, 2 journals used red clover intervention and 1 journal using intervention 
combinations of soy isoflavones and red clover. Soya isoflavones intervention of 50.7 mg, 90 mg, 80 mg, 
100 mg, 70.56 mg, 60 mg, 80 mg, 30 mg genistein and red clover isoflavones as much as 80 mg showed a 
decrease in the incidence of hot flushes. Soy isoflavones intervention of 35 mg, 70 mg and red clover 
isoflavones of 37.1 mg / d did not show a decrease in the incidence of hot flushes. Combination interventions 
of 60.8 mg soy isoflavones and 19.2 mg red clover showed a decrease in the incidence of hot flushes. 
Conclusion: soy isoflavones and red clover isoflavones have a positive effect on reducing the incidence of 
hot flushes in postmenopausal women but a similar study is required with larger numbers of samples and 
corresponding measuring instruments.
1 INTRODUCTION 
Menopause is characterized as decreased levels of 
estrogen and progesterone which can lead to the 
development of some symptoms such as hot flushes, 
night sweats, vaginal dryness, mood disorders, 
decreased libido, insomnia, lethargy or fatigue, 
irritability, anxiety, depression, heart palpitations 
and pain (Borrelli and Ernst, 2010). Hot flushes 
usually occur for at least 1 year to 5 years after 
menstruation ends permanently. Hot flushes in 
menopausal women is a vasomotor response of 
reduced estrogen, a symptom that generally affects 
the quality of life of women and makes women seek 
to perform effective and safe tracments. 
Epidemiological data indicate the highest prevalence 
of hot flushes of 60% are at the age of 52-54 years 
(Ferrari, 2009). Hot flushes incidence of 18% in 
China, 15% in Japan, and 14% in Singapore. While 
in Europe and America, hot flushes incidence could 
reach 80-85% and in Brazilian women reach 70% 
(Thomas et al., 2014).   
Decreased estrogen levels are a major factor in 
loss of bone density, vaginal epithelial atrophy, hot 
flushes and mood changes. A number of women do 
the prevention of menopause symptoms by using 
hormone replacement therapy. Research on the 
effects of hormone replacement therapy by the 
Women's Health Initiative Study (WHI) mentions an 
increased risk of breast cancer and cardiac 
complications early in its use. Thus, many women 
switch by using complementary and alternative 
therapies (Levis et al., 2010) 
Some women use complementary and alternative 
therapies to treat menopausal symptoms by using 
soy products, herbs and other alternative 
complementary therapies. The main reason for the 
use of complementary and alternative therapies is 
the fear of the effects or risks of long-term use of 
hormone replacement therapy (hormone replacement 
therapy). In fact, complementary and alternative 
therapies are safer than hormone replacement 
therapy (Posadzki et al., 2013). The derivative of 
estrogen is phytoesterogen with 3 classification of 
isoflavones, lignans and coumestans. Isoflavones 
were found to have high concentrations in soybeans, 
soy products (such as tofu) and red clover(Borrelli 
and Ernst, 2010). 
In the study of Toku et. All found that soy 
isoflavones given for 6 weeks to 12 months can 
reduce the incidence of hot flushes by almost 21%. 
Many studies on the effectiveness of isoflavones diet 
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against menopausal symptoms. In the current 
systematic review, it will be more focused on the 
effectiveness of soy isoflavones and red algae 
isoflavones facing menopause symptoms especially 
in the event of hot flushes  
2 METHOD  
Literature Search 
This sytematic review includes original journals 
discussing the effects of isoflavones on menopausal 
symptoms as outcomes in general but also in the 
measurements of hot flushes. Systematic literature 
searches are performed in major databases such as 
Proquest, Sciencedirect and Scopus by entering 
isoflavones keywords, hot flushes, menopause. No 
other restrictions are used to maximize literature 
search. The list of literature references is done 
manually. The search results on the scopus database 
as many as 182 journals, ScienceDirect as many as 
637 journals and Proquest 312 journals. 
 
Criteria Inclusion 
The criteria of inclusion of literature are random 
clinical trial (RCT) study on isoflavones 
effectiveness on hot flushes occurrence in 
postmenopausal women with years limit of 10 years 
(2007 - 2017). The research design of RCT must 
meet PICO criteria including the population used are 
menopausal women with both premenopausal, 
menopause transtition, and post menopause with 
history of hot flushes> 4 times a day, intervention of 
isoflavones use as treatment can be extra pure 
soybean, combination and red clover. The 
comparison groups in the study consisted of at least 
two groups: the intervention group and the placebo 
group. The comparison groups in the study consist 
of two groups: the intervention group and the 
placebo group.  All studies use English. Of the total 
journals of 1131 journals, there are 13 journals that 
match the criteria of inclusion of researchers and 
made material systematic review.  
3 RESULTS 
Literature Characteristic Systematic Review  
From 13 journals, data collection is done in United 
Nasition of America as much as 1 journal, Canada 1 
journal, Korea 1 journal, Italy 3 journals, Brazil 2 
journals, New Delhi 1 journal, Denmark 1 journal, 
Nepal 1, Austria 1 journal and Taiwan 1 journal. The 
total sample in the literature was 1398 samples. A 
total of 3 journals involving Asian women, 9 
journals involving western women (caucaisan) and 1 
journal involving multi-ethnic women are white 
spanic, white non spanic, Asian and African. All 
journals are journals with randomized control trial 
design designs with 8 journals using double blinded, 
1 unblended journal, 1 journal of multicenter 
comparative study and 3 other journals not 
explaining in detail.   
 
Isoflavones Intervenstion  
From 10 journals, total of seven journals using pure 
soy extract with isoflavone dose of 70 mg 
(Fontvieille, Dionne and Riesco, 2017), 50,7 mg 
(Levis et al., 2010), 90 mg (Carmignani et al., 
2010), , 60 mg (Franciscis et al., 2017), 100 mg 
(Nahas et al., 2007), 35 mg (Yang et al., 2012), and 
70 mg (Lee, Choue and Lim, 2017), and 80 mg  
(Ferrari, 2009). Two journals used combined 
soybean extract with isoflavone dose of 70.56 mg, 
and 80 mg (Davinelli et al., 2017). One journal uses 
30 mg of ganestein (Evans et al., 2011). 
Two journals using red clover with isoflavones 
of 37.1 mg / d (Lambert et al., 2017), 80 mg 
(Lipovac et al., 2012), 60.8 mg  mg One journifer 
combination of 60.8 mg soy isoflavones and 19.2 
mg red algae isoflavones (Mainini G, 2013). 
Characteristics of isoflavones dose can be seen in 
table 2. 
.  
Measuring Hot Flushes 
Measurement of hot flushes analysis in one journal 
using matlab software. As for other journals, hot 
flushes are always measured along with other 
components. Existing measuring instruments are 
usually a combination of menopausal symptoms. 
However, in each measurement there are several 
journals that include hot flushes diary to record hot 
flushes every day. Measurements used in the journal 
include Kupperman index used to assess vasomotor 
symptoms of menopausal women including hot 
flushes, Menopause Rating Scale (MRS) is used to 
evaluate the symptoms of menopause divided into 3 
sub-somatic somatic (including hot flushes), 
psychological symptoms, and urogenital symptoms, 
Greene Climacteric Scale to measure psychological, 
vasomotoric, somatic, depression and anxiety on the 
subject, and Cooperman's index questionare 
 
The influence of isoflavones on hot flushes 
The results of the journal analysis revealed 9 out of 
10 journals using extra pure soy intervention with 
isoflavones of 50.7 mg, 90 mg, 80 mg, 60 mg, and 
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100 mg, combined soybean intervention combined 
with isoflavones 70.56 mg, 60 mg, 80 mg the 30 mg 
genistein intervention showed a decrease in the 
incidence of hot flushes in postmenopausal women. 
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Figure 1. Process selection of Paper 




































From 2 journals, 1 journal with intervention of 
red algae isoflavones as much as 80 mg showed 
decreased incidence of hot flushes in menopausal 
women. While the combined intervention between 
soy isoflavones 60.8 mg and isoflavones 19.2 mg. 












Table 1. The Value of Hot Flushes Decreased 
4 DISCUSSION 
Isoflavones contained in soy extract and red clover 
extract (Lambert et al., 2017). Research with 
intervention of extra isoflavones of pure soybean, 
genistein and combined soy isoflavones resulted in a 
significant reduction in the incidence of menopausal 
hot flushes. The structure of soybeans has an 
equation with 17 B-estradiol, the female main sex 
hormone (Thomas et al., 2014)   
Based on the analysis of 10 journals, extra 
isoflavones of soybeans are in the range of 30-100 
mg. There is one journal using combined 
monoteraphy genistein, with the result that it 
decreases the incidence of hot flushes in the 
intervention group by 51% with p = 0.009 (Lambert 
et al., 2017). There are 3 studies using the same 
extra soy as much as 200 mg but with different 
isoflavones ie 1 journal containing 50.7 mg and 2 
Author Decreased of Hot Flushes 
Lee, H. et all. (2017) 





Fontvieile, A. (2017) 
Extra soybean tablets 
Negative 
ρ=0.131 
Franciscis, P. et all (2017) 
Extra soybean tablets 
Positive 
Significant to 
ntervention group from 
4.31 to 2.12 
Davinelli, et all (2016) 
Fermentation of soybean 
Positive 
ρ<0.001 
Yang, T (2011) 


















Extra soybean tablets 
Positive 
Significant to 
intervention group 41.2% 
Nahas (2007) 
Extra soybean tablets 
Positive 
ρ<0.001 
Lambert, M. et all (2017) 
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journals containing 80 mg with different population 
numbers. The 12 week intervention in a sample of 
60 Italian women resulted in a significant decrease 
in the incidence of hot flushes by 74.3%. The 24-
week intervention in a sample of 248 multiethnic 
women resulted in a decrease in hot flushes with a 
standard deviation of 12.58 + 6.87. The 12 weeks 
intervention in a sample of 120 Italian women 
showed a decrease in hot flushes in the intervention 
group by 41.2%. 
Based on the analysis of these results showed the 
limit of extra consumption of soybeans in its role 
reduce the incidence of hot flushes in menopausal 
women more than 70 mg / day. This is in line with 
the statement of the European Food Safety Authority 
(EFSA) which confirms that the consumption of at 
least 150 mg of extra soy isoflavones daily for 3 
years can increase hormones in sensitive tissues such 
as in breast, endometrium and gland tyroid (Schmidt 
et al., 2016).  
In addition to being found in soybeans, 
isoflavones are also present in red clover. Soybean 
has 3 main structures of isoflavones in the form of 
glycoside ie genistin, daidzin and glycitin. While the 
main structure of red clover is 4 isoflavones 
including formononetin, biochanin A, daidzein and 
genistein. Both act as esterogenic in the female body 
(Jacobs et al., 2009).  
A study by Lambert et.All on the administration 
of extra red clover isoflavones combined with 
probiotics showed no significant difference between 
the placebo group and the intervention with p = 0.18. 
This study uses extra red clover which is combined 
as much as 13.5 liters and consumed for 90 days 
with isoflavones content of 37.1 mg / d. This study 
describes hot flushes as primary outcomes and 
assessment of the respondent to the time of the sleep 
cycle.  
The average characteristics of the study sample 
were women aged 40-60 years. A decrease in the 
incidence of hot flushes with intervention of more 
than 12 weeks gave more valid results compared to 
shorter duration (Schmidt et al., 2016) Of the 13 
journals, there are 4 journals with female 
populations focusing on women with post 
menopausal, 1 journal with pre menopausal 
population and other journals based on female age 
between 40-60 years unnoticed. Level of 
characteristic of menopause level can be seen in 
table 3 Characteristics of menopausal level of 
research sample. Women with pre menopasue can 
cause a higher placebo response than women with 
post menopause (Liu and Eden, 2007).   
The use of soy isoflavones and red algae to 
control the incidence of hot flushes in menopausal 
women requires an evaluation of the impact on 
women's health. The limitation of this systematic 
review is the difficulty of comparing results with 
diverse interventions, ranging from doses, 
compositions and measuring instruments 
 
Table 2. The Dose of Isoflavones In the Study












Lee, H. et all. (2017) 
Extra soybean tablets 
 
35.28 mg Lactose powder 15.6%, 
cilica dioxide (0.5%) and 
magnesium stearate (0.5%) 
- 2  70.56 mg positive 
Fontvieile, A. (2017) 
Extra soybean tablets 
17.5 mg  - Physic 
exercise  
4 70 mg negative 
Franciscis, P. et all 
(2017) 
Extra soybean tablets 
 
60 mg Lactobacillus 109 spores, 
50 mg ekstra magnolia 
officanilus, 40 mg ekstrak 
vitex agnus castus, 35 mg 
vitamin D  
- 1 60 mg positive 




80 mg 25 mg resveratrol from vitis 
vinifera 
- 1 80 mg positive 
Yang, (2011) 
Extra soybean tablets 






- - 1 51.7 mg positive 
Carmignani (2010) 
Extra soybean tablets 
45 mg - - 2 90 mg positive 
Evans (2010) 
Tablet genistein 
- - 30 mg 
genistein 
1 30 mg positive 
Ferrari (2009) 80 mg - - 1 80 mg positive 
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Table 3. Characteristic Level of Menopause Study Sampl 
Extra soybean tablets 
Nahas (2007) 
Extra soybean tablets 
100 mg - - 2 100 mg positive 
Lambert, M. et all 
(2017) 
Extra red clover 
37.1 mg/d  - - Not 
speci
fic 
Not specific negative 
Lipovac (2012) 
Capsule of red 
clover 
80 mg - - 1 80 mg positive 
Mainini (2012) 
Suplement of red 
clover and soybean 
60.8 mg - -  60.8 mg positive 
Author Age of  Study Sample Menopause Level Total 
Sample 
Decreased of Hot 
Flushes 
Lee, H. et all. (2017) 
Extra soybean tablets 
45-60 Not Specific 84 Positive 
Fontvieile, A. (2017) 
Extra soybean tablets 
50 -70 Post Menopause 31 Negative 
Franciscis, P. et all 
(2017) 
Extra soybean tablets 
Not Specific Post Menopause 180 Positive 
Davinelli, et all (2016) 
Fermentation of 
soybean 
50-55 Menopause 60 Positive 
Yang, T  (2011) 
Extra soybean tablets 
Not Specific Menopause 130 Negative 
Levis (2010) 
ekstra protein kedelai  
45-60 Peri Menopause 248 Positive 
Carmignani (2010) 
Extra soybean tablets 
40-60 Menopause 60 Positive 
Evans (2010) 
Tablet genistein 
45-65 Menopause 84 Positive 
Ferrari (2009) 
Extra soybean tablets 
40-65 Not Specific 120 Positive 
Nahas (2007) 
Extra soybean tablets 
Rate 55,1 Not Specfic 80 Positive 
Lambert, M. et all 
(2017) 
Extra red clover 
40-65 Tahun Peri Menopause 62 Negative 
Lipovac (2012) 
Capsule of red clover 
.>40 Post Menopause 109 Positive 
Mainini (2012) 
Suplement of red clover 
and soybean 
Not Specific Post Menopause 150 Positive 
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5 CONCLUSION 
Systematic review of the effects of isoflavones on 
hot flushes occurrence in menopausal women 
provides a solution for further research. In a 
randomized control trial study, there will be 2 
groups: the placebo group and the intervention 
group, to avoid a higher placebo response, it is 
necessary to have participant criteria, in a 
homogeneous level of menopause  
Giving extra isoflavones to soybeans in either 
pure form or combination and red clover isoflavones 
positively impacted the decrease in the incidence of 
hot flushes in postmenopausal women but a similar 
study was required with larger numbers of samples 
and corresponding measuring instruments. Use of 
hot flushes as outcomes primar provides a more 
specific assessment of hot flushes variable.   
The implication that can be taken is to know 
about alternative actions in reducing hot flushes. 
Nursing paradigm with 4 pillars of human in the 
sense of menopausal women, environment is defined 
as an environment that provides a choice of attitudes 
in menopausal women, healt illness is defined as 
how the experience of menopausal women in the 
face of menopausal symptoms in the form of 
adaptive or maladaptive and nurse is defined as how 
the nurse see this phenomenon. Interventions given 
to women who are menopausal need to be informed 
to maintain reproductive health. 
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